Altogether, we demonstrated that serum EV-derived miRNA-105-5p could be transferred to ESCC cells and foster the progression of ESCC by targeting SPARCL1 and regulating the FAK/Akt signaling pathway. The gene discussed is SPARCL1; the disease is esophageal squamous cell carcinoma.